About Trpti™

Trpti™: The body's way of naturally producing GLP-1

Trpti™ is OEA powered by LipiSperse® technology by Pharmako Biotechnologies Pty Ltd. The LipiSperse shepherds OEA through the GI tract and delivers OEA efficiently to the intestines, where it best enhances the production of the bodyʼs own GLP-1. This ensures no side effects, unlike the synthetic GLP-1 agonists, which can have a myriad of side effects

About Trpti About Trpti

WHY us

Why choose Trpti™

Oleoylethanolamide (OEA) is a fatty acid amide produced by the body that signals to our brain that we are full. OEA plays a role in regulating appetite and energy balance.

OEA binds to GPR-119 to produce GLP-1 in the body's intestines naturally.

The accumulated data suggest that OEA may be involved in various pathophysiological aspects of appetite regulation and lipid and carbohydrate metabolism.

  • It is essential for the body's homeostasis and metabolic function.
  • It acts on inflammation, but also offers satiety, fat management, lipid management, glucose control, body mass, body weight, BMI, and body fat.

That's where Trpti™ offers an advantage.

REGULAR OEA

OEA traditionally, is not easily absorbed by the body and has very low bioavailability.

TRPTI™

Trpti™ is easily absorbed by the body, enhancing bioavailability, by optimizing OEA for its full benefit potential because of lipisperse technology.

APPLICATIONS

Trpti formats